Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood advances. 2026; 10(5):1783-1798.
Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s252-s253.
Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. Blood advances. 2026; 10(6):1967-1976.
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report. Transplantation and Cellular Therapy. 2026; 32(1):89.e1-89.e10.
CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved Dose. Pediatric Blood and Cancer. 2026; e70268.
Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population. Pediatric Pulmonology. 2026; 61(3):e71508.
Clinical Decision-Making in Hematopoietic Cell Transplantation (HCT) for Severe Aplastic Anemia (SAA): Insights from a National Survey of Physicians. Transplantation and Cellular Therapy. 2026; 32(2):s318-s319.
Got Nutrition? Exclusion of Nutrition Intervention at Key Points during Hematopoietic Stem Cell Transplantation Negatively Impacts Frailty. Transplantation and Cellular Therapy. 2026; 32(2):s607-s608.
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study. Journal of Human Immunity. 2026; 2(1):e20250163.
Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.
Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers. Clinical Immunology. 2026; 283:110658.
Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective. Pediatric Blood and Cancer. 2026; 73(3):e70001.
Assessment of Oral Health Practices for Patients Receiving Stem Cell Transplantation at Pediatric Oncology Centers. Transplantation and Cellular Therapy. 2026; 32(2):s315-s316.
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplantation and Cellular Therapy. 2026; 32(1):12.e1-12.e4.
Impact of Iron Overload on Hematopoietic Stem Cell Transplant in Children with Non-Malignant Hematological Disorders. Blood advances. 2026.
Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease. Transplantation and Cellular Therapy. 2026.
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2026; 32(2):199.e1-199.e12.
Neutrophil extracellular traps, endothelial injury and use of abatacept for graft versus host disease prophylaxis. Haematologica. 2026.
Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults. Bone Marrow Transplantation. 2026.
Targeting the lectin pathway in TA-TMA. Blood advances. 2026; 10(1):181-182.
A Multicenter Quality Improvement Initiative to Reduce Central Venous Catheter Line Days after Transplant Cellular Therapy across the Engraft Learning Health Network. Transplantation and Cellular Therapy. 2026; 32(2):s360-s361.
Stem cell transplantation and gene therapy for telomere biology disorders: Historical perspective, current approaches, and emerging strategies. Seminars in Hematology. 2026.
Proteomic analysis of pericardial effusions in hematopoietic stem cell transplant recipients. Haematologica. 2026; 111(4):1484-1489.
Radiation-Free Reduced-Intensity Conditioning Achieves Excellent Outcomes in Pediatric Severe Aplastic Anemia. Transplantation and Cellular Therapy. 2026; 32(2):s581.
Lower Isn't Better: Baseline LDL-C Identifies Endothelial Vulnerability and Outcomes after HSCT. Elsevier; 2026:s594.
Liver disease in Shwachman-Diamond syndrome: A comprehensive characterization across the age spectrum. Journal of Pediatric Gastroenterology and Nutrition. 2026.
Longitudinal Outcomes of Reproductive Function in Male Pediatric Hematopoietic Stem Cell Transplant Survivors. Transplantation and Cellular Therapy. 2026; 32(2):s356.
Activating Epic’s Flowsheet for Standardized Chronic GVHD Assessment: A Multi-Center Implementation Framework to Enable Standardized Documentation. Transplantation and Cellular Therapy. 2026; 32(2):s520-s521.
The evolving landscape of primary hemophagocytic lymphohistiocytosis: Long-term outcomes following hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology. 2026; 157(2):340-341.
Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies-an ASTCT-NMDP ACCESS Initiative. Transplantation and Cellular Therapy. 2026.
2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS). Annals of Allergy, Asthma and Immunology. 2026; 136(4):426-493.e1.
2’-Fucosyllactose (Human Milk Oligosaccharide) Reduces Dysbiosis and Acute GI GVHD in Children and Young Adults Following HSCT: A Prospective, Single-Center Phase II Study. Transplantation and Cellular Therapy. 2026; 32(2):s570.
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC. Blood advances. 2026; 10(3):887-900.
MCP-1 in Broncho-Alveolar Fluid and Plasma in Children with Lung Injury after Hematopoietic Stem Cell Transplant: A Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s581-s582.
“to Bronch or Not to Bronch? - Biologic Markers of Lung Injury in the Bronchoalveolar Lavage Fluid of Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, a Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s584-s585.
Relationship between Social Drivers of Health and Clinician Adherence to Late Effects Screening Among Allogeneic HCT Survivors in the United States. Transplantation and Cellular Therapy. 2026; 32(2):s24-s25.
Automated data extraction model for the USIDNET registry: Bigger, faster, and better data collection. Journal of Human Immunity. 2026; 2(1):e20250118.
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study. Blood advances. 2026; 10(5):1564-1575.